SLC1A2 and major depressive disorder: In this context, altered expression of glutamate transporter-1 (GLT-1) was described in MDD patients [128], but also selective blockade of GLT-1 induced depressive-like behaviors in rodents [18], both affecting glutamatergic signaling.